SMTL ID : 4yhi.2 (1 other biounit)

Reversal Agent for Dabigatran

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.90 Å

Oligo State

hetero-1-1-mer

Ligands

1 x 4CC: N-[(2-{[(4-carbamimidoylphenyl)amino]methyl}-1-methyl-1H-benzimidazol-5-yl)carbonyl]-N-pyridin-2-yl-beta-alanine(Non-covalent)

4CC.1: 17 residues within 4Å: Chain A: T.30, D.31, Y.33, H.35, E.50, N.52, R.54, G.102, Y.103, D.104, Y.105, F.106 Chain B: E.39, Y.41, F.94, A.96, Y.101 14 PLIP interactions: 12 interactions with chain A, 2 interactions with chain B Hydrophobic interactions: A:Y.103, A:F.106, B:Y.101 Water bridges: A:H.35, A:R.54, A:R.54, A:G.99, A:G.99, A:G.102 Salt bridges: A:R.54 pi-Stacking: A:Y.33, A:H.35 pi-Cation interactions: A:R.54 Hydrogen bonds: B:E.39

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Schiele, F. et al., Structure-guided residence time optimization of a dabigatran reversal agent. Mabs (2015)

Release Date

2016-01-13

Peptides

aDabi-Fab2a heavy chain: A
aDabi-Fab2a light chain: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
H

B
L

aDabi-Fab2a heavy chain

aDabi-Fab2a light chain

Related Entries With Identical Sequence